Sanofi.
French pharmaceutical company
- Reports this week
- 0
- Active events
- 3
- Connections
- 163
What's happening
Active this week
-
Sanofi and Abbott face supply limitations in Pakistan, prompting drug inspectors to operate in Lahore.Some support3 reports1 development inside
-
Abbott Laboratories and Sanofi confirmed the presence of fake vaccines circulating in Pakistan.Some support1 report
-
Sanofi is discussing vaccine supply and immunization programs in Iraq.Some support1 report
Earlier this month
-
Sanofi reported a 68% climb in collaboration revenue while its shares traded on the Nasdaq exchange.Some support1 report
-
Sanofi and Regeneron Pharmaceuticals announced a profit split for Dupixent and expanded their antibody alliance.Some support1 report
-
IDT Biologika and SK Bioscience are co-developing a pneumococcal vaccine with Sanofi, supported by BARDA and CEPI, to address BDBV outbreaks in Zaire.Some support1 report
-
AbbVie and others are managing drug exclusivity, seeking next-gen immunology pipeline growth, and competing for market share.Well supported3 reports4 developments inside
-
Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.Well supported4 reports2 developments inside
-
Sanofi and Recursion Pharmaceuticals formed a partnership to develop AI-enabled therapies.Some support1 report
-
Sanofi Canada operates within the British Columbia region.Some support1 report
-
Texas AG Ken Paxton sued pharmaceutical companies Sanofi and Bristol-Myers Squibb over alleged drug concealment.Some support1 report
-
Sanofi and DSCHC formed a public-private partnership to commission new clinics in Aniocha North LGA, Delta State, Nigeria.Some support1 report
-
Sanofi, Hoffmann-La Roche, Gilead, and Pfizer announced a collaboration to co-develop bexobrutideg, with Sanofi providing a $10M milestone payment.Some support1 report
-
Steinberg held leadership positions at Sanofi, a company that has been operating in Vietnam for nearly 75 years.Some support1 report
One to three months ago
-
Sanofi and the Association of Science and Technology Centers announced a partnership focused on environmental education.Some support1 report
-
Industry experts met in San Diego, involving representatives from Sanofi, Cardinal Health, and Marsh.Some support1 report
-
Sanofi removed Sjögren's from frexalimab and Novartis discontinued iscalimab in Sjögren's.Some support1 report
-
Sanofi formed a strategic partnership with Cheplapharm, gaining a 26.4% equity stake in the company in exchange for mature medicines and sites.Some support1 report
-
Advocates partner in a Breathe Equal campaign to raise awareness and push for government prioritization of respiratory health.Some support1 report
-
Premier Doug Ford attended the opening of a new facility involving Sanofi.Some support1 report
-
Julien Perrier previously held senior roles at both AbbVie and Sanofi.Some support1 report
-
Sanofi and Regeneron Pharmaceuticals announce a joint initiative to develop Praluent cholesterol medication and initiatives like TrumpRx.gov.Some support2 reports1 development inside
-
Sanofi completed the repayment of a development balance.Some support1 report
-
Sanofi utilized VTEX for advertising campaigns, while VTEX also facilitated Iberdrola's presence in Spain and Dolce & Gabbana's e-commerce in Brazil.Some support2 reports
-
Sanofi operates in the United States and internationally, including Europe.Some support2 reports
-
The Kennect platform is handling incentive payouts for Cipla, involving both Cipla and Sanofi.Some support2 reports
-
Scribe Therapeutics secured funding through a private placement with Sanofi and received grant support from CIRM.Some support1 report
-
Saudi Arabia signed an MoU with Sanofi to boost health cooperation and R&D/clinical research.Some support1 report
-
Michael Ehlers, a former executive at Pfizer and Biogen, is noted, alongside Sanofi backing Formation Bio.Some support1 report
-
Collaboration revenue streams are shared between Sanofi and Gilead Sciences.Some support1 report
Gone quiet
No new reports in 90+ days-
A critical strategic collaboration has formed involving Hoffmann-La Roche, Recursion, Recordati, Moderna, Sanofi, and Merck KGaA to diversify pipelines through automated biological research.Some support1 report1 development inside
-
Sanofi initiated a Phase 1 clinical trial collaboration with Nurix Therapeutics, utilizing its drug discovery platform.Some support1 report
-
Sanofi reported strong Q2 sales growth and raised its outlook.Some support1 report
-
Sanofi was involved in a major collaboration that is generating $2.2 billion in revenue.Some support1 report
-
Sanofi abandoned the development of amlitelimab in a deal involving Malin Corporation.Some support1 report
-
Benzinga reported on the stock price activity of Sanofi on July 24, 2026.Some support1 report
-
Sanofi is experiencing intermittent supply issues within the U.S.Some support1 report
-
Citigroup reiterated a neutral rating on Sanofi stock while Morgan Stanley boosted its holdings.Some support3 reports
-
Citigroup reaffirmed a neutral rating on Sanofi stock.Some support1 report
-
Sanofi, Scribe Therapeutics, and Biogen are partnering on ALS gene therapy research, seeking a second research deal and initial public offering on Nasdaq.Some support2 reports
-
Competitors acquired companies involved in the same market, and Lynn Seely was appointed to the company's Board of Directors.Some support1 report
-
Sanofi failed to provide required documentation for PBS listing.Some support1 report
-
Adocia has regained global rights to M1Pram after Sanofi's exclusive negotiation period expired.Some support1 report
-
Michael Goettler, CEO of Knoa Pharma, previously held senior roles at Pfizer and Sanofi.Some support1 report
-
Talawar Therapeutics and Sanofi are joining forces via a definitive business combination agreement, planning a Nasdaq debut.Some support1 report
-
Investigations have been launched focusing on communications at Sanofi in Germany and France.Some support1 report
-
AbbVie is taking steps to offset competitive pressures within the pharmaceutical market, involving Sanofi and Johnson & Johnson.Some support1 report
-
Sanofi is bringing innovative treatment options for rare disease patients in Japan, with Hisashi Kato affiliated with a hospital in Suita.Some support1 report
-
Sanofi's stock price hit a 52-week low of $42.26 on June 18, 2026.Some support1 report
-
Sanofi participated in a funding round led by Lumira Ventures and co-led by Roche Venture Fund.Some support1 report
-
BASF and Sanofi are sponsoring the activities at the Morristown Farmers Market.Some support1 report
-
Sanofi, a company headquartered in Paris, France, was the subject of the news.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Explainers that pass through Sanofi
Sanofi is a step on the way to someone else- Sanofi's new vaccine development requires FDA regulatory oversightSanofi's new vaccine development requires FDA regulatory oversightPossible
- Greater Boston biotech boom may raise opportunities for Monte Rosa TherapeuticsIncreased biotech investment in Greater Boston may boost Monte Rosa Therapeutics' valuation and partnerships.Possible
- Competitors' rapid biologic advances may challenge AstraZeneca's market positionIncreased investment in biologics may intensify competitive pressure on AstraZenecaPossible
- FDA may face increased demand from advanced biologic pipelineFDA may face increased demand to review complex, AI-driven biologic submissionsPossible
Around Sanofi this week
News at the entities that move Sanofi most-
FDA StructuralThe FDA approved Miplyffa for the treatment of Niemann-Pick disease.Moves Sanofi
-
Regeneron Pharmaceuticals OperationalMorgan Stanley dropped price target and Cantor Fitzgerald reduced price target on Regeneron Pharmaceuticals stock.Moves Sanofi
-
Morgan Stanley TransactionalSurrozen utilized conference platforms hosted by Morgan Stanley in South San Francisco on September 1, 2026.Moves Sanofi
-
Steinberg StructuralSteinberg, Manley, Aaron Hoffman, and Hart are listed as voters in Gallatin County.Moves Sanofi
-
Nigeria StructuralNESG monitored business performance across Nigeria on November 6, 2026.Moves Sanofi
-
Citigroup OperationalRaymond James Financial, Boston Partners, and GQG Partners raised holdings in Allstate, and Citigroup boosted its target price on the company.Moves Sanofi
Connections
The 40 strongest of 163, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Regeneron Pharmaceuticals Operational
Sanofi and Regeneron maintain a strategic partnership for joint development, marketing, and profit sharing of pharmaceutical products.
-
Paulo Fontoura Structural
Sanofi formally employed Paulo Fontoura as EVP, Global Head of R&D Pharma.
-
Belén Garijo Structural
Belén Garijo serves as the CEO of Sanofi, driving corporate strategy and R&D pipeline reviews.
-
FDA Structural
The FDA regulates Sanofi's drug development and approval process, establishing a formal regulatory dependence.
-
Sachin Jain Structural
Sachin Jain is involved in a leadership change at Sanofi, which is currently viewed favorably by investors.
-
Rebecca Cotton Structural
Rebecca Cotton holds the position of head of patient support at Sanofi.
-
Gilead Operational
Sanofi and Gilead collaborated on a project that generated $27M in earnings.
-
Department of Health, Disability and Ageing Structural
The Department of Health establishes the regulatory requirements for PBS listing, which is necessary for Sanofi's market access.
Show all 40 connections
-
George Yancopoulos Operational
Sanofi and George Yancopoulos are involved in a major collaboration generating $2.2 billion in revenue.
-
Gilead Sciences Operational
The two companies are engaged in an active collaboration where revenue streams are shared.
-
Novavax Operational
An active commercial partnership exists where Sanofi's operations and revenue streams support Novavax's market momentum and product commercialization.
-
Recursion (United States) Operational
The two companies are engaged in a critical strategic alliance focused on automated biological research and shared development goals.
-
Pfizer Operational
Sanofi and Pfizer are engaged in a collaboration that has generated $27M in earnings.
-
Saudi Arabia Operational
Formal collaboration established via a signed Memorandum of Understanding for joint R&D and clinical research activities.
-
Morgan Stanley Transactional
Morgan Stanley provides investment recommendations and price targets for Sanofi stock.
-
Steinberg Structural
Steinberg held leadership positions at Sanofi.
-
Monroe County Structural
Sanofi operates a campus in Monroe County, establishing a functional presence dependent on the county's jurisdiction and infrastructure.
-
Cipla Structural
Sanofi operates the Kennect platform which handles incentive payouts for Cipla.
-
Novartis Operational
The two companies are active competitors in the pharmaceutical market, evidenced by drug performance comparisons.
-
Michael Goettler Structural
A previously held senior roles at B, establishing a structural link between the individual and the company.
-
Nigeria Structural
Sanofi is involved in a Public-Private Partnership (PPP) with Nigeria.
-
AbCellera Operational
The entities are competitors operating in the same market, driven by market acquisitions and consolidation.
-
VTEX Transactional
Sanofi utilized VTEX's platform to manage and execute its advertising campaigns.
-
Hoffmann-La Roche Transactional
Sanofi and Hoffmann-La Roche have engaged in both competitive activities and a recent milestone payment.
-
Delta State Operational
Sanofi and Delta State are engaged in a public-private partnership.
-
Citigroup Operational
Citigroup provided a neutral rating on Sanofi, indicating professional market coverage.
-
AbbVie Operational
AbbVie and Sanofi are actively competing in the market for Dupixent's share through product offerings.
-
Stellantis Mentioned together
Both companies publicly committed to the SDG 5 Pledge for global sustainability.
-
Kymera Therapeutics Operational
Kymera Therapeutics is actively competing with Sanofi for market position in the pharmaceutical sector.
-
Association of Science and Technology Centers Operational
The entities are engaged in a partnership focused on environmental education.
-
RBC Capital Markets Mentioned together
Financial analysts provide commentary on Sanofi.
-
Donald Trump Mentioned together
The relationship is based on a single forecast suggesting that AI stocks benefit from potential Trump-era tariffs and onshoring policies.
-
Infosys Mentioned together
Both Sanofi and Infosys were mentioned as examples of stocks driving a market rally.
-
Amgen Operational
The two companies are active competitors in the pharmaceutical market, exemplified by Sanofi's strategic product indication changes.
-
Doug Ford Transactional
The relationship is defined by a specific, current event where the company's facility opening was attended by Premier Doug Ford.
-
Ken Paxton Transactional
Ken Paxton initiated a lawsuit against Sanofi concerning drug concealment.
-
Shirley Ballas Operational
Partnered in the Breathe Equal campaign to raise awareness.
-
company Shared context
Sanofi is observed performing typical corporate activities, placing it within the general context of a company.
-
Iraq Shared context
Sanofi operates in Iraq, participating in vaccine supply and immunization programs.
-
Pakistan Operational
Sanofi actively operates in Pakistan, facing supply limitations and regulatory issues related to its pharmaceutical presence.
History
Events by the month they beganNovember 2026
2 eventsOctober 2026
10 events- Sanofi and Abbott face supply limitations in Pakistan, prompting drug inspectors to operate in Lahore.
- Sanofi reported a 68% climb in collaboration revenue while its shares traded on the Nasdaq exchange.
- Sanofi and Regeneron Pharmaceuticals announced a profit split for Dupixent and expanded their antibody alliance.
- IDT Biologika and SK Bioscience are co-developing a pneumococcal vaccine with Sanofi, supported by BARDA and CEPI, to address BDBV outbreaks in Zaire.
- Sanofi and Recursion Pharmaceuticals formed a partnership to develop AI-enabled therapies.
- Sanofi Canada operates within the British Columbia region.
- Texas AG Ken Paxton sued pharmaceutical companies Sanofi and Bristol-Myers Squibb over alleged drug concealment.
- Sanofi and DSCHC formed a public-private partnership to commission new clinics in Aniocha North LGA, Delta State, Nigeria.
- Sanofi, Hoffmann-La Roche, Gilead, and Pfizer announced a collaboration to co-develop bexobrutideg, with Sanofi providing a $10M milestone payment.
- Steinberg held leadership positions at Sanofi, a company that has been operating in Vietnam for nearly 75 years.
September 2026
12 events- Sanofi and the Association of Science and Technology Centers announced a partnership focused on environmental education.
- Industry experts met in San Diego, involving representatives from Sanofi, Cardinal Health, and Marsh.
- Sanofi removed Sjögren's from frexalimab and Novartis discontinued iscalimab in Sjögren's.
- Sanofi formed a strategic partnership with Cheplapharm, gaining a 26.4% equity stake in the company in exchange for mature medicines and sites.
- Advocates partner in a Breathe Equal campaign to raise awareness and push for government prioritization of respiratory health.
- Premier Doug Ford attended the opening of a new facility involving Sanofi.
- Julien Perrier previously held senior roles at both AbbVie and Sanofi.
- Sanofi completed the repayment of a development balance.
- Sanofi utilized VTEX for advertising campaigns, while VTEX also facilitated Iberdrola's presence in Spain and Dolce & Gabbana's e-commerce in Brazil.
- Sanofi operates in the United States and internationally, including Europe.
- The Kennect platform is handling incentive payouts for Cipla, involving both Cipla and Sanofi.
- Scribe Therapeutics secured funding through a private placement with Sanofi and received grant support from CIRM.
Show 3 earlier months
August 2026
5 events- Saudi Arabia signed an MoU with Sanofi to boost health cooperation and R&D/clinical research.
- Michael Ehlers, a former executive at Pfizer and Biogen, is noted, alongside Sanofi backing Formation Bio.
- Collaboration revenue streams are shared between Sanofi and Gilead Sciences.
- Sanofi initiated a Phase 1 clinical trial collaboration with Nurix Therapeutics, utilizing its drug discovery platform.
- Sanofi reported strong Q2 sales growth and raised its outlook.
July 2026
13 events- Sanofi and Regeneron Pharmaceuticals announce a joint initiative to develop Praluent cholesterol medication and initiatives like TrumpRx.gov.
- A critical strategic collaboration has formed involving Hoffmann-La Roche, Recursion, Recordati, Moderna, Sanofi, and Merck KGaA to diversify pipelines through automated biological research.
- Sanofi was involved in a major collaboration that is generating $2.2 billion in revenue.
- Sanofi abandoned the development of amlitelimab in a deal involving Malin Corporation.
- Benzinga reported on the stock price activity of Sanofi on July 24, 2026.
- Sanofi is experiencing intermittent supply issues within the U.S.
- Citigroup reiterated a neutral rating on Sanofi stock while Morgan Stanley boosted its holdings.
- Citigroup reaffirmed a neutral rating on Sanofi stock.
- Sanofi, Scribe Therapeutics, and Biogen are partnering on ALS gene therapy research, seeking a second research deal and initial public offering on Nasdaq.
- Competitors acquired companies involved in the same market, and Lynn Seely was appointed to the company's Board of Directors.
- Sanofi failed to provide required documentation for PBS listing.
- Adocia has regained global rights to M1Pram after Sanofi's exclusive negotiation period expired.
- Michael Goettler, CEO of Knoa Pharma, previously held senior roles at Pfizer and Sanofi.
June 2026
10 events- AbbVie and others are managing drug exclusivity, seeking next-gen immunology pipeline growth, and competing for market share.
- Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.
- Talawar Therapeutics and Sanofi are joining forces via a definitive business combination agreement, planning a Nasdaq debut.
- Investigations have been launched focusing on communications at Sanofi in Germany and France.
- AbbVie is taking steps to offset competitive pressures within the pharmaceutical market, involving Sanofi and Johnson & Johnson.
- Sanofi is bringing innovative treatment options for rare disease patients in Japan, with Hisashi Kato affiliated with a hospital in Suita.
- Sanofi's stock price hit a 52-week low of $42.26 on June 18, 2026.
- Sanofi participated in a funding round led by Lumira Ventures and co-led by Roche Venture Fund.
- BASF and Sanofi are sponsoring the activities at the Morristown Farmers Market.
- Sanofi, a company headquartered in Paris, France, was the subject of the news.